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Abstract. Using two types of anti-phosphopeptide anti- 
bodies which specifically recognize vimentin phosphor- 
ylated by protein kinase C (PKC) at two distinct PKC 
sites, we found that PKC acted as a mitotic vimentin ki- 
nase. Temporal change of vimentin phosphorylation by 
PKC differed from changes by cdc2 kinase. The mito- 
sis-specific vimentin phosphorylation by PKC was dra- 
matically enhanced by treatment with a PKC activator, 
12-O-tetradecanoylphorbol-13-acetate (TPA), while no 
phosphorylation of vimentin by PKC was observed in 
interphase cells treated with TPA. By contrast, the dis- 
ruption of subcellular compartmentalization of inter- 
phase cells led to vimentin phosphorylation by PKC. 
Cytoplasmic and nuclear membranes are fragmented 
and dispersed in the cytoplasm and some bind to vi- 
mentin during mitosis. Thus, targeting of activated 
PKC, coupled with the reorganization of intracellular 
membranes which contain phospholipids essential for 
activation, leads to the mitosis-specific phosphorylation 
of vimentin. We propose that during mitosis, PKC may 
phosphorylate an additional subset of proteins not 
phosphorylated in interphase. 
p 
ROTEIN kinase C  (PKC)  1 is  a  phospholipid-depen- 
dent serine/threonine kinase which plays a key role 
in signal transduction (Nishizuka,  1988, 1992). Re- 
cent studies suggest that PKC may function in regulating 
specific facets of the cell cycle. PKC inhibitors such as H7 
and calphostin C inhibit cell cycle progression in G1 phase 
(Usui et al.,  1991; Mifiana et al., 1992). In primitive  eu- 
karyote Saccharomyces cerevisiae,  a  PKC-related  gene, 
PKC1, was proposed to be essential  for cell growth and 
the G2-M transition of yeast (Levin et al., 1990; Levin and 
Bartlett-Heubusch, 1992). Cells overexpressing  the 8 sub- 
species are arrested at the G2/M phase by treatment with a 
phorbol ester (Watanabe et al., 1992). However, there is a 
small number of direct target substrates for PKC involved 
in progressing  the cell cycle. For example,  1311 PKC trans- 
locates to the nucleus during the G2/M phase of cell cycle, 
leading to the phosphorylation of a cytoskeletal protein 
lamin B which, since lamin B is part of the nuclear lamina, 
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might influence stability of the nuclear lamina structure 
(Goss et al., 1994). 
We reported that intermediate filaments (IFs) are perti- 
nent in vitro PKC substrates (Inagaki et al., 1987a, 1988, 
1990; Gonda et al., 1990; Yano et al., 1991b). During mito- 
sis, IFs undergo dynamic change in organization accompa- 
nied with phosphorylation. It has been reported that the 
reorganization of cytoplasmic  IFs during mitosis is medi- 
ated by phosphorylation of vimentin by cdc2 kinase (Chou 
et al., 1990; Matsuoka et al., 1992; Tsujimura et al., 1994), 
but it has also been reported that multiple kinases are re- 
sponsible for the phosphorylation of vimentin during mi- 
tosis, which may function in conjunction with cdc2 kinase 
in mediating IF reorganization (Evans,  1989; Chou et al., 
1990). However, only cdc2 kinase has been identified as a 
mitotic vimentin kinase. 
To investigate  the pathway of signaling between PKC 
and vimentin, we recently developed the monoclonal anti- 
body YT33 which recognizes  the phosphorylated state of 
vimentin by PKC at its specific site  of phosphorylation, 
Ser33 (Ogawara et al., 1995). Using  antibody YT33, we 
found that in differentiated astrocytes, endogenous PKC 
activated by phosphatidylinositol 4,5-bisphosphate  (PIPE) 
hydrolysis or a phorbol ester did not lead to phosphoryla- 
tion of vimentin by PKC. Because ectopic expression  of 
constitutively active PKC induced Ser33-phosphorylation 
of vimentin and reorganization of its filament networks, 
we considered that activated PKC is kept apart from vi- 
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PKC signaling to vimentin during the cell cycle remains to 
be investigated. 
In the present study, we used the antibody YT33 and the 
newly  developed  antibody  TM50  which  recognize  the 
phosphorylated  states  of  vimentin  by  PKC  at  distinct 
phosphorylation sites. We report here that PKC acts as an 
in vivo vimentin kinase  specifically during mitosis.  The 
compartmentalization between activated PKC and vimen- 
tin filaments in mitotic cells differs from that in interphase 
cells.  We discuss the putative mechanism in which PKC 
phosphorylates a cytoskeletal protein vimentin specifically 
during mitosis. The spatial change of activated PKC may 
be regulated by reorganization of intracellular membranes 
which supply PKC with phospholipids indispensable for 
activation. 
Materials and Methods 
Preparation of  Proteins 
Recombinant vimentin was prepared from E. coli as described previously 
(Ogawara et al., 1995). The catalytic subunit of cAMP-dependent protein 
kinase (A kinase), Ca2+-calmodulin--dependent protein kinase II  (CaM 
kinase II), PKC, and cdc2 kinase were prepared as described previously 
(Beavo et al.,  1974;  Yamauchi and Fujisawa, 1983;  Inagaki et al.,  1985, 
1987b;  Kusubata et al., 1992).  Protein concentrations were measured ac- 
cording to Bradford (1976) with bovine serum albumin as standard. Puri- 
fied vimentin (0.15  mg/ml) was phosphorylated by incubation with 5 p,g/ 
ml of the catalytic subunit of A kinase, 5 Izg/ml of PKC, 0.5 i~g/ml of cdc2 
kinase, or 5 I~g/ml of CaM kinase II, as described previously (Tsujimura et 
al., 1994). 
Peptide Synthesis 
Vimentin peptides, PV6 (Cys-Ser-Thr-Arg-Ser-Val-phosphoSerr-Ser-Ser  - 
Ser-Tyr-Arg), PV24 (Cys-Thr-Ser-Ser-Arg-Pro-phosphoSer24-Ser-Asn-Arg- 
Ser-Tyr), PV33 (Cys-Ser-Tyr-Val-Thr-Thr-phosphoSera3-Thr-Arg-Thr-Tyr  - 
Ser), V33 (Cys-Ser-Tyr-Val-Thr-Thr-Sera3-Thr-Arg-Thr-Tyr-Ser),  PV41 (Cys- 
Thr-Tyr-Ser-Leu-Gly-phosphoSer41-Ala-Leu-Arg-Pro-Ser),  PV50 (Cys-Pro- 
Ser-Thr-Ser-Arg-phosphoSerS°-Leu-Tyr-Ser-Ser-Ser),  V50 (Cys-Pro-Ser-Thr- 
Ser-Arg-SerS°-Leu-Tyr-Ser-Ser-Ser),  PV55  (Ser-Leu-Tyr-Ala-Ser-phos- 
phoSer55-Pro-Gly-Gly-Val-Tyr-Cys), PV65 (Cys-Tyr-Val-Thr-Arg-Ser-phos- 
phoSer65-Ala-Val-Arg-Leu-Arg), and PV82 (Cys-Arg-Leu-Leu-Gln-Asp- 
phosphoSera2-Val-Asp-Phe-Ser-Leu) were synthesized as described previ- 
ously (Tsujimura et al., 1994). 
Preparation of Mouse-Monoclonal Antibodies 4A4 
and YT33 
Mouse-monoclonal antibodies  against  PV55  (4A4)  and  PV33  (YT33) 
were prepared as described previously (Matsuoka et al., 1992; Tsujimura 
et al., 1994; Ogawara et al., 1995). 
Production of Rat-Monoclonal Antibody TM50 
Phosphopeptide PV50 was conjugated to keyhole limpet hemocyanin and 
injected into female Jcl:Wister rats via hind footpads. The enlarged medial 
iliac lymph nodes from the injected rats were used for cell fusion after the 
method described in detail elsewhere (Kishiro et al., 1995). 
Cell Preparation 
U251 human astrocytoma cells and MDBK bovine kidney cells were cul- 
tured in Dulbecco's modified Eagle's medium containing 10% FCS. 
Immunofluorescence Microscopy and Western Blotting 
Immunofluorescence microscopy was performed according to the previ- 
ously described method (Nishizawa et al., 1991), with slight modifications. 
Cells grown on cover glasses were fixed for 10 min with 3.7% formalde- 
hyde in PBS, permeabilized for 20 min with 0.5% Triton X-100 in PBS, 
and  then visualized by immunofluorescence, using YT33  (3  I~g/ml)  or 
TM50 (3 ~g/ml) in PBS, as first antibodies. All the procedures for West- 
ern blotting have been described in detail  elsewhere  (Nishizawa et  al., 
1991; Yano et al., 1991a). 
Preparation of lnterphase and Mitotic Cell Lysates  for 
Western Blotting 
Cell lysates of interphase and mitotic cells for Western blotting were pre- 
pared  according to  the previously described  method (Tsujimura et  al., 
1994)  with slight modifications. Just before cells reached confluence, 10 
ng/ml colcemid was added to the culture media, and 12 h later the mitotic 
cells were collected by gently shaking the culture flasks. For the collection 
of interphase cells, cells were  cultured to  reach confluence and a  small 
number of mitotic cells were removed by gently shaking the flasks, and 
then cells adhering to the bottom of the flasks were used as the interphase 
cells. After washing with cold PBS, cell pellets were dissolved in SDS sam- 
ple buffer, which contained 0.2 mg/ml Bromophenol blue, 10% glycerol, 
100 mM 2-mercaptoethanol (2-ME), 2% SDS, and 62.5 mM Tris-HC1 (pH 
6.8), with brief sonication. 
Preparation of the Cytosol and Membrane Fractions of 
U251 Cells 
The cytosol and membrane fractions of U251 cells were prepared accord- 
ing to the previously described method (Chida et al.,  1986)  with slight 
modifications. Interphase and mitotic U251  ceils were  prepared  as de- 
scribed above. After incubation in the presence or absence of 200 nM 12-0- 
tetradecanoylphorbol-13-acetate (TPA), 2.0 x  106 cells were washed with 
cold PBS and suspended in buffer A  consisting of 2 mM ethylene glycol- 
bis (13-aminoethyl ether)  N,N,N',N',-tetraacetic acid (EGTA), 50 p,g/ml 
leupeptin, 50 mM 2-ME and 25 mM Tris-HC1 (pH 7.5). The cells were 
then homogenized and centrifuged at 100,000 g for 30 min. The superna- 
tant  was  subjected  to  chromatography on  a  DEAE-cellulose  (DE-52; 
Whatman) column (0.6 ×  1.0 cm) equilibrated with buffer A. The fraction 
eluted with 0.4 M NaC1 was used as the preparation of the cytosol fraction. 
The crude membrane fraction (100,000 g  precipitate) was solubilized by 
treatment with buffer A  containing 1.0% Triton X-100 at 4°C for 30 min 
and centrifuged at 100,000 g for 30 min. The supernatant was subjected to 
chromatography on a DEAE-cellulose column (0.6 x  1.0 cm) equilibrated 
with buffer A. The column was washed with 5 ml of buffer A without Tri- 
ton X-100. The fraction eluted with 0.4 M NaC1 was used as the prepara- 
tion of the membrane fraction. 
Assay of Protein Kinase C 
PKC  activity  was  assayed  by  measuring  incorporation  of  32p  from 
[~/-32p]ATP to histone H1 according to the previously described method 
(Inagaki et al., 1985) with slight modifications. Each fraction (5 izl) was in- 
cubated at 25°C for 5 min with 0.5 mg/ml histone H1 (Boehringer Mann- 
heim Corp., Indianapolis, IN) in a reaction mixture containing, in a final 
volume of 25 Ixl, 10 ~M [3,-32p]ATP, 0.1 p,M calyculin A, 1 mM EGTA or 
0.1 mM CaC12, 2 mM MgCI2 and 25 mM Tris-HCl (pH 7.5), in the pres- 
ence or absence of 200 nM TPA and 50 p,g/ml phosphatidylserine (PS). 
The reaction was stopped by adding 25 p~l of cold 300 mM H3PO4 and the 
mixture was spotted onto a P81 phosphocellulose paper. The papers were 
washed successively three  times for 5  min in 75  mM H3PO  4 and once 
briefly in ethanol, dried, and then counted in a liquid scintillation counter. 
Activity of PKC was defined as the difference between the 32p incorpora- 
tion in the presence and absence of CaC12, TPA, and PS. 
Phosphorylation of Purified Vimentin by the Cytosol 
and Membrane Fractions of U251 Cells 
Each fraction was incubated at 25°C for 30 min with 0.15 mg/ml vimentin 
as an exogenous substrate in a reaction mixture containing 1.0 mM ATP, 
0.1 p,M calyeulin A, 1.2 mM MgC12 and 25 mM Tris-HCl (pH 7.5), in the 
presence or absence of 200 nM TPA, 50 p~g/ml  PS, and 0.1 mM CaCI  2. The 
reaction was stopped by adding equal volume of SDS sample buffer. 
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Cell Lysates of U251 Cells 
Interphase and mitotic U251 cells with or without TPA treatment were 
suspended and sonicated in a buffer  consisting of 0.5 mM dithiothreitol, 20 
mM ~-glycerophosphate,  50 }xg/ml  leupeptin, 10 mM 2-ME, 2 mM PMSF 
and 25 mM Tris-HC1 (pH 7.5). The whole cell lysates (0.6 mg protein/ml) 
containing endogenous vimentin  were incubated at 25°C for 30 min in a 
reaction mixture containing 1.0 mM ATP, 0.1 }xM calyculin A, 1.2 mM 
MgC12, 2 mM PMSF, and 25 mM Tris-HC1 (pH 7.5). The reactions were 
stopped by adding an equal volume  of SDS sample  buffer. 
Results 
Is PKC a Mitotic Vimentin Kinase? 
We  recently  developed  the  monoclonal  antibody  YT33 
against a synthetic phosphopeptide PV33 (_P_hosphorylated 
Vimentin  Set33;  Cys-Ser-Tyr-Val-Thr-Thr-phosphoSer  a3- 
Thr-Arg-Thr-Tyr-Ser, residues  28-38  of vimentin)  (Oga- 
wara et al., 1995).  Vimentin-Ser33 has been identified as a 
PKC phosphorylation site in vitro (Ando et al., 1989). 
The reactivity of the antibody YT33 to nonphosphory- 
lated  vimentin  and  phosphorylated  vimentin  by various 
protein kinases was analyzed by Western blotting. Recom- 
binant  mouse nonphosphorylated vimentin and vimentin 
phosphorylated by cAMP-dependent protein kinase, PKC, 
cdc2 kinase,  and  CaE÷-calmodulin-dependent  protein ki- 
nase  II  were  resolved  by  SDS-PAGE,  and  blots  were 
stained with the antibody YT33 (Fig. 1 A). The antibody 
YT33 reacted only with vimentin phosphorylated by PKC 
and did not react with nonphosphorylated vimentin or vi- 
mentin phosphorylated by other protein kinases. Next, we 
examined the sensitivity of the antibody YT33 to phosphor- 
ylated vimentin by PKC (Fig. 1 B). While vimentin has 11 
known  sites  of phosphorylation  for  PKC  (Ando  et  al., 
1989), the antibody YT33 showed sensitivity high enough 
to detect vimentin phosphorylated at 0.3  mol phosphate/ 
mol vimentin by PKC. We also examined the specificity of 
the  antibody YT33  to vimentin phosphorylated at  Set33 
(Fig. 1 C). It was neutralized by preincubation exclusively 
with a  phosphopeptide PV33 but not with a  peptide V33 
(Cys-Ser-Tyr-Val-Thr-Thr-Sera3-Thr-Arg-Thr-Tyr-Ser)  or 
other phosphopeptides  such as PV6,  PV24,  PV41,  PV50, 
and  PV65  which  were  designed  to  represent  vimentin 
phosphorylated at known PKC sites such as Ser6,  Ser24, 
Ser41, Ser50, and Ser65, respectively. 
To  observe  the  in  vivo  phosphorylation  of vimentin- 
Ser33 residues during the cell cycle, U251 human astrocy- 
toma cells  and  MDBK bovine kidney cells were  stained 
with the  YT33  antibody.  As we noted previously in pri- 
mary cultured astrocytes (Ogawara et al., 1995), U251 and 
MDBK cells in interphase showed no YT33 immunoreac- 
tivity. On the other hand, YT33 immunostained an intri- 
cate mesh of vimentin filament in the entire cytoplasm of 
mitotic cells (Fig. 2, A  and B). These results suggest that 
vimentin-Ser33 is phosphorylated specifically during mitosis. 
To confirm the  mitosis-specific phosphorylation  of vi- 
mentin-Ser33, Western blots were prepared. Whole cell ly- 
sates  of interphase  and  mitotic  U251  and  MDBK  cells 
were stained with the YT33 antibody. As shown in Fig. 2, 
C and D, prominent immunoreactive bands at 57 kD were 
visible in  lysates  obtained  from mitotic cell  fractions  of 
both U251 and MDBK cells. Since vimentin migrates at a 
Figure 1.  Immunoreactivity of the antibody YT33 analyzed by 
Western  blotting.  (A)  Recombinant vimentin was  phosphory- 
lated  by cAMP-dependent protein kinase  (A  kinase-vim.) (c), 
protein kinase C (C kinase-vim.) (d),  cdc2 kinase (e), or Ca  2+- 
calmodulin-dependent protein kinase II (CaM kinase II-vim.  ) (Y3, 
respectively.  0.75 Ixg of the protein was loaded in each lane and 
stained  with the antibody YT33 (1 I~g/ml). The same amount of 
nonphosphorylated vimentin was loaded in lanes (a) and (b) and 
stained with Coomassie brilliant blue and the antibody YT33, re- 
spectively. (B) Sensitivity of the antibody YT33 was assayed. 0.75 
Ixg of vimentin phosphorylated by protein kinase C at 0.3 (b), 1.0 
(c), and 2.0 (d) mol phosphate/mol vimentin were loaded in each 
lane and stained  with  the antibody YT33  (1  i~g/ml). Nonphos- 
phorylated vimentin was loaded in lane (a). (C) Specificity of the 
antibody YT33 was  assayed.  0.75 txg of recombinant vimentin 
phosphorylated by protein kinase C was loaded in each lane and 
stained  with the antibody YT33 (1 Ixg/ml) after absorption with 
synthetic peptides (50 txg/ml of V33 (b), PV33 (c), PV6 (d), PV24 
(e), PV41 (J), PV50 (g) or PV65 (h)). Lane (a) shows the reactiv- 
ity of YT33 after preincubation with PBS. The position of vimen- 
tin is indicated  (arrowhead). 
position corresponding to a molecular mass of 57 kD, the 
results shown in Fig. 2, C  and D  provide strong evidence 
that the appearance of immunoreactivities with use of the 
antibody YT33 in  cell staining  truly represents the pres- 
ence of vimentin-phosphoSer33 residues during mitosis. 
Temporal Change of Vimentin-Ser33 Phosphorylation 
by PKC during Mitosis 
We then examined the temporal change of phosphoryla- 
tion-dephosphorylation of vimentin-Ser33 observed in mi- 
totic U251 cells. Ser33-phosphorylation was started at meta- 
phase and maintained  throughout  anaphase  as shown in 
Fig. 3 A. Similar results were obtained when MDBK cells 
were stained (data not shown). These patterns of staining 
differed from those of a monoclonal antibody 4A4 which 
specifically recognizes cdc2 kinase-phosphorylated vimen- 
tin (Fig. 3 B; Tsujimura et al., 1994). Thus, PKC may act as 
a  mitotic vimentin kinase on a  time schedule that differs 
from vimentin phosphorylation by cdc2 kinase. 
Antibody Specific to Phosphorylated Vimentin at a 
Distinct PKC Site, Ser50 
To determine whether or not PKC is a mitotic vimentin ki- 
nase, we  developed another monoclonal  antibody TM50 
Takai et al. Mitosis-specific Vimentin  Phosphorylation by PKC  143 Figure 2.  (A  and B)  Immunofluorescence micrographs of U251  human astrocytoma cells (A) and  MDBK  bovine kidney cells (B) 
stained with the antibody YT33 (3 ~zg/ml). Propidium iodide was mixed in the embedding solution to visualize chromosomes (red). The 
bar represents 10 Ixm. (C and D) Western blotting of interphase and mitotic U251 and MDBK cells. The same amount of cell lysates ob- 
tained from ~5 ×  104 cells was loaded in each lane and stained with Coomassie brilliant blue (C) and the antibody YT33 (D). The posi- 
tion of vimentin is indicated (arrowhead). I, interphase cells; M, mitotic cells. The markers used were phosphorylase B (Mr 97,000), bo- 
vine serum albumin (Mr 66,000), ovalbumin (Mr 43,000), and carbonic anhydrase (M  r 31,000). 
which  specifically  recognizes  the  Ser50-phosphorylated 
state of vimentin. Vimentin-Ser50 is another site of phos- 
phorylation for PKC in vitro (Ando et al., 1989). Western 
blotting  indicated that  the  antibody  TM50  reacted  with 
phosphorylated vimentin by PKC but not with  nonphos- 
phorylated vimentin, and that it was neutralized by prein- 
cubation with a  phosphopeptide PV50  (Cys-Pro-Ser-Thr- 
Ser-Arg-phosphoSerS°-Leu-Tyr-Ser-Ser-Ser) but  not  with 
Figure 3.  Immunofluorescence micrographs of mitotic U251  cells stained with the antibody YT33 (A) or 4A4 (B). The bar represents 
10 ~m. 
The Journal of Cell Biology, Volume 133, 1996  144 Figure 4.  Immunoreactivity of the antibody TM50 revealed by Western blotting (A and B) and immunofluorescence  micrography (C). 
(A) 0.75 p,g of recombinant vimentin phosphorylated by protein kinase C was loaded in each lane and stained with the antibody TM50 
(1 p~g/ml)  after absorption with synthetic peptides (50 p~g/ml  of V50 (b), PV50 (c), PV6 (d), PV24 (e), PV33 (f), PV41 (g) or PV65 (h)). 
Lane (a) shows the reactivity of TM50 after preincubation with PBS. (B) Western blotting of interphase (a) and mitotic (b) U251 cells. 
The same amount of cell lysates was loaded in each lane and stained with the antibody TM50. (C) Immunofluorescence rnicrographs of 
mitotic U251 cells stained with the antibody TM50 (3 p,g/ml). The bar represents 10 Ixm. 
a  peptide  V50  (Cys-Pro-Ser-Thr-Ser-Arg-SeIS°-Leu-Tyr  - 
Ser-Ser-Ser)  or  a  phosphopeptide  such  as  PV6,  PV24, 
PV33, PV41, and PV65 (Fig. 4 A). 
In Western blotting using whole cell lysates and TM50, 
an immunoreactive band at the position corresponding to 
that of vimentin was visible in the mitotic but not in the in- 
terphase cell lysate (Fig. 4 B). Immunofluorescence micro- 
graphy using TM50 revealed that another PKC site Ser50 
on vimentin was also phosphorylated, specifically during 
mitosis. Furthermore, temporal change of Ser50-phosphor- 
ylation during mitosis was much the same as that of Ser33- 
phosphorylation (Fig. 4 C). These results strongly suggest 
that PKC is a mitotic vimentin kinase. 
Mitosis-specific Enhancement by TPA of Vimentin 
Phosphorylation  by PKC 
To  further  elucidate  whether  the  mitosis-specific Ser33- 
and Ser50-phosphorylation of vimentin was carried out by 
PKC, we asked whether or not the PKC-activator, 12-0- 
tetradecanoylphorbol-13-acetate  (TPA)  would  enhance 
these types of vimentin phosphorylation. As shown in Fig. 
5,  the  mitosis-specific Ser33-phosphorylation  was signifi- 
cantly enhanced  by treatment  with TPA  (large  arrows). 
On the other hand, TPA had no effect on vimentin phos- 
phorylation  by PKC  in  interphase  U251  cells  (small ar- 
rows), findings consistent with our previous results using 
differentiated astrocytes (Ogawara et al., 1995). Similar re- 
sults  were  obtained when  MDBK  cells  instead  of U251 
cells were stained and also when the antibody TM50 was 
used instead of YT33 (data not shown). Western blotting 
revealed about three times the degree of enhancement of 
mitosis-specific Ser33-phosphorylation by TPA treatment 
(Fig. 6, A  and B). Interphase cells were not stained with 
the  antibody YT33  even  when  U251  cells  were  treated 
with a phosphatase inhibitor calyculin A  (10 nM) alone or 
with calyculin A  and TPA (data not shown). After 20-30 
min in the presence of calyculin A, an increasing number 
of the  cells showed  a  more rounded  morphology as  de- 
scribed previously (Eriksson et al.,  1992),  but interphase 
cells were not stained with the  antibody YT33  (data not 
shown). These results suggest that PKC can phosphorylate 
vimentin specifically in mitotic cells and not in interphase 
cells,  even in  case  of TPA  and/or  phosphatase  inhibitor 
treatment. 
Subcellular Localization of PKC Activity in Interphase 
and Mitotic Cells 
To investigate mechanism(s) involved in the mitosis-spe- 
cific  vimentin  phosphorylation  by  PKC,  we  examined 
whether  PKC  is  activated when  cells  enter  mitosis.  Be- 
cause PKC is redistributed from the cytosol to the mem- 
brane fraction when activated by PIP  2 hydrolysis or phor- 
bol  esters  (Kraft  and  Anderson,  1983),  we  checked  the 
subcellular localization of PKC activity in interphase and 
mitotic U251  cells. PKC activity of each subcellular frac- 
tion was assayed by measuring incorporation of phosphate 
into histone H1 (Fig. 7 A). In interphase U251 cells, ~70% 
of the PKC activity was found in the cytosol fraction and 
30% in the membrane fraction. In mitotic U251 cells, the 
subcellular localization of PKC activity was similar to that 
in interphase ceils. 
Next, we wanted to determine if PKC is activated when 
Takai et al. Mitosis-specific  Vimentin  Phosphorylation  by PKC  145 Figure 5.  Effects of TPA on the phosphorylation of vimentin at Ser33 residues in U251 cells. Cells were treated with buffer alone (A 
and B) or 200 nM TPA for 30 rain (C and D), stained with antibody YT33 (3 ~g/ml), and photographed in short (A and C, 1.6 s) or long 
(B and D, 6.4 s) exposure time. Note that Ser33-phosphorylation  in mitotic U251 cells (large arrows) was significantly enhanced by TPA, 
while no Ser33-phosphorylation  was observed in interphase U251 cells (small arrows), even when treated with TPA. The bar represents 
10 Ixm. 
interphase  and  mitotic  cells  are  treated  with  TPA.  By 
treatment with 200 nM TPA, the PKC activity in the cyto- 
sol  fraction  of both  interphase  and  mitotic  cells  disap- 
peared almost completely while the activity in the mem- 
brane fraction increased to the level almost equal to the 
total PKC activity seen in untreated cells (Fig. 7 A). 
Instead of histone HI, we incubated purified vimentin as 
an exogenous substrate with each fraction, which was de- 
pleted of endogenous vimentin and membrane phospho- 
lipid, in the presence or absence of PKC activators such as 
TPA,  phosphatidylserine  (PS)  and  CaC12, and  then  as- 
sayed the  activity for Ser33-phosphorylation of vimentin 
by Western blotting using the YT33 antibody. No Ser33- 
phosphorylation  was  detected  when  vimentin  was  incu- 
bated in  the  absence of PKC activators (Fig.  7 B; upper 
panel). In the presence of PKC activators, vimentin-Ser33- 
phosphorylation demonstrated almost the same subcellu- 
lar localization of the activity as demonstrated by histone 
Hl-phosphorylation (Fig. 7 B; lower panel). These results 
support the possibility that PKC is the only protein kinase 
in intcrphase and mitotic cell lysates which phosphorylates 
vimentin-Ser33. 
Subcellular localization of PKC activity assayed by mea- 
suring phosphorylation of histone H1 and vimentin-Ser33 
Figure 6.  Western blotting of interphase (a and b) and mitotic (c 
and d) U251 cells with (b and d) or without (a and c) treatment of 
TPA. (A) Same amount of cell lysates obtained from ,'-,5 ×  104 
cells was loaded in each lane and stained with the antibody YT33. 
(B) The density of each blot in A was measured by densitometer 
and expressed as ratio to the density of the blot from mitotic cells 
without treatment. 
The Journal of Cell Biology,  Volume 133, 1996  146 Figure 7.  PKC activity in the cytosol and membrane fractions  of 
U251 cells assayed by phosphorylation of histone H1 (.4) or vi- 
mentin (B). The cytosol (a, c, e, and g) and membrane (b, d,f, and 
h) fractions  were obtained from 2.0 x  106 interphase (a-d) and 
mitotic (e-h) U251 cells with (c, d, g, and h) or without (a, b, e, 
and D TPA treatment. Each fraction was incubated with 0.5 rng/ 
ml histone  H1 (A) or 0.15 mg/ml vimentin (B). (B) 1.875 Ixg of 
the  vimentin  samples  phosphorylated  in  the  presence  (lower 
panel) or absence (upper panel) of TPA, FS,  and  CaC12 were 
loaded for each lane and stained with the antibody YT33. 
suggests that PKC redistribution does not occur when cells 
enter mitosis and that PKC is redistributed  and activated 
by TPA treatment in both interphase and mitotic cells. In 
other words, the mitosis-specific vimentin phosphorylation 
by PKC is not coupled with PKC redistribution. 
Disruption of SubceUular Compartmentalization 
of Interphase Cells Leads to Vimentin Phosphorylation 
by PKC 
Interphase  and  mitotic U251  cells with  or  without  TPA 
treatment were sonicated and whole cell lysates were pre- 
pared.  After  the  incubation  of whole  cell  lysates in  the 
presence  of ATP,  Ser33-phosphorylation  of endogenous 
vimentin was detected in the whole cell lysates prepared 
from interphase cells as well as in those from mitotic cells 
(Fig.  8).  Moreover,  a  significantly higher  level of Set33- 
phosphorylation of vimentin was observed in  the sample 
prepared from TPA-treated interphase cells, compared to 
untreated  interphase  cells.  Similar results were  obtained 
when mitotic cells were used.  These results indicate  that 
the disruption  of subcellular compartmentalization of in- 
terphase ceils leads to vimentin phosphorylation by PKC. 
Discussion 
In the present study, we presented evidence for the in vivo 
phosphorylation  of vimentin by PKC  specifically during 
mitosis, using  two types of phosphorylated state-specific 
antibodies (Figs. 1--4). Furthermore, we demonstrated that 
TPA-induced  enhancement  of vimentin phosphorylation 
by PKC is also mitosis-specific (Figs. 5 and 6). In addition 
to these observations, we tried to inhibit Set33- and Ser50- 
phosphorylation of vimentin during mitosis using PKC in- 
hibitors such  as H7  and  calphostin  C.  However, it was 
impossible to obtain evidence for inhibition of the mitosis- 
specific Set33- or SerS0-phosphorylation by PKC inhibitors 
because they prevented cells from entering mitosis (Usui 
et al., 1991; Mifiana et al., 1992). 
Why vimentin phosphorylation by PKC is mitosis-spe- 
cific has to be addressed.  Subcellular localization of PKC 
in  mitotic cells is  similar to  that  in  interphase  cells,  and 
TPA induces PKC redistribution  from the cytosol to the 
membrane fraction  in  both  interphase  and  mitotic  cells 
(Fig. 7).  Since the disruption  of subcellular compartmen- 
talization of interphase cells leads to vimentin phosphory- 
lation  by PKC  (Fig.  8),  we  propose mechanisms for the 
mitosis-specific phosphorylation of vimentin by PKC out- 
lined in Fig. 9. In interphase cells (Fig. 9 A), the majority 
of PKCs are distributed in the cytosol fraction while some 
PKCs are distributed in the membrane fraction. When in- 
terphase cells are treated with TPA (Fig. 9 B), most PKCs 
in the cytosol fraction are redistributed to the membrane 
fraction.  The  membrane-bound PKCs  cannot  encounter 
and phosphorylate vimentin because of structural organi- 
zation  of intracellular  membranes such  as nuclear  enve- 
lopes (NE), endoplasmic reticulums (ER),  and Golgi ap- 
paratus.  When  cells  enter  mitosis  (Fig.  9  C),  however, 
structure of the intracellular membranes disassemble into 
Figure 8.  PKC activity in the whole cell lysates 
of U251 cells assayed by phosphorylation of en- 
dogenous  vimentin.  Interphase (a, b, e, and f) 
and mitotic (c, d, g, and h) cells with  (b, d, f, 
and h) or without  (a, c, e, and g) TPA treat- 
ment  were  sonicated  and  whole  cell  lysates 
were prepared. The same amount of each ly- 
sate (,--,1-2 X  104 ceils)  was loaded for each 
lane before (a-d) or after (e-h) the incubation 
with  ATP,  and  then  stained  with  Coomassie 
brilliant  blue  (A) or the  antibody YT33  (B). 
Endogenous vimentin in the mitotic cell lysates 
was phosphorylated at Ser33 without  the incu- 
bation (c and d). 
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Figure 9.  Schematic representation of the mechanism of mitosis- 
specific phosphorylation  of vimentin filament by protein kinase 
C. Activated  protein kinase  C (AC) was assumed to be almost 
membrane-bound  whereas inactive protein kinase C (IC) to be 
almost  cytosolic. ER,  endoplasmic  reticulum;  MV, membrane 
vesicles; NE, nuclear envelope; PM, plasma membrane; Vim, vi- 
mentin filament. P denotes the phosphorylation  of vimentin fila- 
ment by protein kinase C. 
the form of vesicles (MV, membrane vesicles) (Zeligs and 
Wollman, 1979; Gerace and Blobel, 1980). Thus, the MV- 
bound PKCs do encounter and phosphorylate vimentin. In 
TPA-treated mitotic cells (Fig. 9 D), an increased number 
of MV-bound PKCs encounter and phosphorylate vimen- 
tin. In other words, the mitosis-specific vimentin phosphor- 
ylation by PKC may be caused by mitosis-specific target- 
ing of activated PKC to vimentin coupled with reorganization 
of intracellular membranes. 
It has been reported that vimentin filaments bind under 
in vitro conditions to vesicles reconstituted from total cel- 
lular lipids and phospholipid mixtures (Traub et al., 1986). 
Vimentin is also known to form a filament basket around 
lipid globules present in differentiating adipocytes. The IF 
basket is "sandwiched" between the surface of the globule 
and a flat, fenestrated membrane cisterna (Franke et al., 
1987). It was also reported that vimentin filaments of mi- 
totically arrested cells are associated with nuclear mem- 
brane vesicles and that their binding to vimentin is modu- 
lated by phosphorylation and dephosphorylation (Maison 
et aL, 1993).  These vimentin-membrane interactions sup- 
port our proposal (Fig. 9) for mechanisms by which PKC 
exerts activity to phosphorylate vimentin specifically dur- 
ing mitosis. 
Like the vimentin phosphorylation, phosphorylation of 
other PKC substrates may possibly be regulated by mito- 
sis-specific targeting coupled with the reorganization of in- 
tracellular membranes. Therefore, our proposal also im- 
plies  that  during  mitosis,  PKC  may  phosphorylate  an 
additional subset of substrates not phosphorylated in in- 
terphase. 
Phosphorylated  state-specific  antibodies  which  recog- 
nize the phosphorylated serine/threonine residue and its 
flanking sequence provide a  useful tool to  analyze site- 
specific protein phosphorylation of a target protein in vivo 
(Nishizawa et al.,  1991; Czernik et al.,  1991; Matsuoka et 
al.,  1992;  Inagaki et al.,  1994a,b).  Analysis of an in vivo 
substrate  of  a  kinase  is  feasible  using  phosphorylated 
state-specific antibodies, if they are raised against unique 
phospho-serine/threonine  residues  which  are  specifically 
catalyzed by the kinase  in vitro (Tsujimura et  al.,  1994; 
Ogawara et al.,  1995).  In the present study, we obtained 
evidence for the in vivo phosphorylation of vimentin by 
PKC in the cell cycle, the visualization of which was made 
feasible by using two monoclonal antibodies which specifi- 
cally recognize vimentin phosphorylated at distinct PKC 
sites. Such findings suggest the spatiotemporal distribution 
of PKC activity in the cytoplasm during mitosis coupled 
with reorganization of intracellular membranes, events not 
recognized by means of anti-PKC antibodies or cell lines 
overexpressing or lacking PKC. 
Because vimentin is localized only in the cytoplasm, de- 
tection of PKC activity in the membrane and nucleus is 
difficult  using  these  antibodies.  However,  as  we  have 
shown, they are powerful tools to monitor the spatiotem- 
poral organization of PKC activity in the cytoplasm. Anal- 
ysis of the functions of activated PKC in  the cytoplasm 
during mitosis is an area for further exploration. 
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